Cargando…
Mifepristone improves chemo-radiation response in glioblastoma xenografts
BACKGROUND: We have investigated the ability of Mifepristone, an anti-progestin and anti-glucocorticoid drug, to modulate the antitumor effect of current standard clinical treatment in glioblastoma xenografts. METHODS: The effect of radiation alone or combined with Mifepristone and Temozolamide was...
Autores principales: | Llaguno-Munive, Monserrat, Medina, Luis Alberto, Jurado, Rafael, Romero-Piña, Mario, Garcia-Lopez, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626552/ https://www.ncbi.nlm.nih.gov/pubmed/23530939 http://dx.doi.org/10.1186/1475-2867-13-29 |
Ejemplares similares
-
Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021) -
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2018) -
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
por: Ocaña-Arakachi, Karen, et al.
Publicado: (2023) -
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2020) -
The Therapeutic Potential of Chemo/Thermotherapy with Magnetoliposomes for Cancer Treatment
por: Toro-Córdova, Alfonso, et al.
Publicado: (2022)